Deutsche Bank’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,645
| Closed | -$3.23M | – | 3630 |
|
|
2025
Q4 | $3.23M | Buy |
14,645
+3,245
| +28% | +$524K | ﹤0.01% | 1519 |
|
|
2025
Q3 | $1.09M | Buy |
11,400
+4,734
| +71% | +$302K | ﹤0.01% | 2113 |
|
|
2025
Q2 | $325K | Buy |
+6,666
| New | +$160K | ﹤0.01% | 2684 |
|
|
2021
Q2 | – | Sell |
-1,244
| Closed | -$66K | – | 4619 |
|
|
2021
Q1 | $66K | Sell |
1,244
-109
| -8% | -$5.38K | ﹤0.01% | 4162 |
|
|
2020
Q4 | $54K | Buy |
1,353
+504
| +59% | +$25.1K | ﹤0.01% | 4094 |
|
|
2020
Q3 | $48K | Buy |
849
+80
| +10% | +$5.65K | ﹤0.01% | 3904 |
|
|
2020
Q2 | $57K | Buy |
+769
| New | +$49.8K | ﹤0.01% | 3745 |
|
|
2020
Q1 | – | Sell |
-217
| Closed | -$16K | – | 4381 |
|
|
2019
Q4 | $16K | Buy |
+217
| New | +$9.93K | ﹤0.01% | 4360 |
|
|
2019
Q3 | – | Sell |
-438
| Closed | -$14K | – | 4916 |
|
|
2019
Q2 | $14K | Sell |
438
-3
| -0.7% | -$125 | ﹤0.01% | 4889 |
|
|
2019
Q1 | $23K | Buy |
+441
| New | +$24.2K | ﹤0.01% | 4759 |
|
|
2018
Q4 | – | Sell |
-877
| Closed | -$77K | – | 5171 |
|
|
2018
Q3 | $77K | Buy |
+877
| New | +$77.4K | ﹤0.01% | 4582 |
|
|
2018
Q2 | – | Sell |
-557
| Closed | -$44K | – | 5425 |
|
|
2018
Q1 | $44K | Sell |
557
-3,442
| -86% | -$470K | ﹤0.01% | 4790 |
|
|
2017
Q4 | $543K | Sell |
3,999
-4,952
| -55% | -$751K | ﹤0.01% | 3550 |
|
|
2017
Q3 | $1.45M | Buy |
8,951
+7,148
| +396% | +$1.02M | ﹤0.01% | 2764 |
|
|
2017
Q2 | $270K | Buy |
1,803
+1,645
| +1,041% | +$227K | ﹤0.01% | 3773 |
|
|
2017
Q1 | $24K | Sell |
158
-247
| -61% | -$43.4K | ﹤0.01% | 4453 |
|
|
2016
Q4 | $82K | Buy |
405
+317
| +360% | +$65.9K | ﹤0.01% | 4173 |
|
|
2016
Q3 | $20K | Buy |
88
+6
| +7% | +$1.39K | ﹤0.01% | 4533 |
|
|
2016
Q2 | $16K | Buy |
82
+46
| +128% | +$11.1K | ﹤0.01% | 4806 |
|
|
2016
Q1 | $9K | Sell |
36
-24
| -40% | -$5.53K | ﹤0.01% | 4843 |
|
|
2015
Q4 | $20K | Sell |
60
-6
| -9% | -$1.8K | ﹤0.01% | 4751 |
|
|
2015
Q3 | $16K | Buy |
66
+8
| +14% | +$2.29K | ﹤0.01% | 4833 |
|
|
2015
Q2 | $16K | Buy |
+58
| New | +$17.8K | ﹤0.01% | 4956 |
|
Deutsche Bank's CDTX Position: Q1 2026 in Review
Deutsche Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 14,645 shares — an estimated $3.23M sold.
Deutsche Bank first reported a position in CDTX in Q2 2015 and held it in 23 quarters. The position peaked at $3.23M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- Deutsche Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- Deutsche Bank sold 14,645 Cidara Therapeutics shares in Q1 2026, an estimated $3.23M.
- Deutsche Bank first reported a position in Cidara Therapeutics in Q2 2015 and held it in 23 quarters.
- Deutsche Bank's Cidara Therapeutics position peaked at $3.23M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.